Literature DB >> 17547839

Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation.

Guenther Boden1, A Koneti Rao.   

Abstract

Tissue factor (TF) is the primary initiator of blood coagulation. Circulating TF procoagulant activity (TF-PCA) is associated with blood cells and microparticles and is elevated in patients with type 2 diabetes mellitus. Combined hyperinsulinemia and hyperglycemia and to a lesser degree selective hyperinsulinemia for 24 hours in healthy volunteers increased circulating TF-PCA, monocyte TF surface expression and mRNA, plasma thrombin generation, and coagulation factors VII and VIII activities, suggesting that the coagulation system had been activated. In addition, platelet CD40L and platelet-monocyte aggregates increased, indicating platelet activation. Somatostatin abolished these changes. We conclude that hyperinsulinemia, but particularly the combination of hyperinsulinemia and hyperglycemia, creates a prothrombotic state and may, in addition, be proinflammatory and proatherogenic by virtue of the actions of CD40L and TF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547839     DOI: 10.1007/s11892-007-0035-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  29 in total

Review 1.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 2.  Tissue factor, the blood, and the arterial wall.

Authors:  U Rauch; Y Nemerson
Journal:  Trends Cardiovasc Med       Date:  2000-05       Impact factor: 6.677

3.  Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

Authors:  N S Key; A Slungaard; L Dandelet; S C Nelson; C Moertel; L A Styles; F A Kuypers; R R Bach
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

4.  Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.

Authors:  W B Kannel; R B D'Agostino; P W Wilson; A J Belanger; D R Gagnon
Journal:  Am Heart J       Date:  1990-09       Impact factor: 4.749

5.  Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.

Authors:  Antonia Sambola; Julio Osende; James Hathcock; Michael Degen; Yale Nemerson; Valentin Fuster; Jill Crandall; Juan Jose Badimon
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

6.  Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.

Authors:  E Morishita; H Asakura; H Jokaji; M Saito; C Uotani; I Kumabashiri; M Yamazaki; K Aoshima; T Hashimoto; T Matsuda
Journal:  Atherosclerosis       Date:  1996-02       Impact factor: 5.162

7.  Blood glucose may condition factor VII levels in diabetic and normal subjects.

Authors:  A Ceriello; D Giugliano; A Quatraro; P Dello Russo; R Torella
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 8.  Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes.

Authors:  H C Kwaan
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

9.  Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.

Authors:  W H Pan; L B Cedres; K Liu; A Dyer; J A Schoenberger; R B Shekelle; R Stamler; D Smith; P Collette; J Stamler
Journal:  Am J Epidemiol       Date:  1986-03       Impact factor: 4.897

10.  Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.

Authors:  R L Jones
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

View more
  18 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

Review 2.  Pathogenesis of diabetic cerebral vascular disease complication.

Authors:  Ren-Shi Xu
Journal:  World J Diabetes       Date:  2015-02-15

3.  Carbohydrate restriction with postmeal walking effectively mitigates postprandial hyperglycemia and improves endothelial function in type 2 diabetes.

Authors:  Monique E Francois; Etienne Myette-Cote; Tyler D Bammert; Cody Durrer; Helena Neudorf; Christopher A DeSouza; Jonathan P Little
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-13       Impact factor: 4.733

4.  Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.

Authors:  Rehab S El-Hagracy; Gihan M Kamal; Inas M Sabry; Abeer A Saad; Nahla F Abou El Ezz; Hesham A R Nasr
Journal:  Oman Med J       Date:  2010-07

5.  Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes.

Authors:  Joseph Pidala; Jongphil Kim; Mohamed A Kharfan-Dabaja; Taiga Nishihori; Teresa Field; Janelle Perkins; Lia Perez; Hugo Fernandez; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2010-07-15       Impact factor: 5.742

Review 6.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

Review 7.  Obesity and free fatty acids.

Authors:  Guenther Boden
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

Review 8.  Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis.

Authors:  Xiaoling Li; Nina C Weber; Danny M Cohn; Markus W Hollmann; J Hans DeVries; Jeroen Hermanides; Benedikt Preckel
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

9.  The relationship between insulin sensitivity and serum antithrombin 3 activity in patients with type 2 diabetes.

Authors:  Hong Wang; Jie Cao; Jian-Bin Su; Xue-Qin Wang; Dong-Mei Zhang; Xiao-Hua Wang
Journal:  Endocr Connect       Date:  2021-06-23       Impact factor: 3.335

Review 10.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.

Authors:  Francesco Paneni; Joshua A Beckman; Mark A Creager; Francesco Cosentino
Journal:  Eur Heart J       Date:  2013-05-02       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.